🇺🇸 Investigational drug in United States

673 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 99 reports (14.71%)
  2. Nausea — 80 reports (11.89%)
  3. Pyrexia — 71 reports (10.55%)
  4. Anaemia — 70 reports (10.4%)
  5. Dehydration — 67 reports (9.96%)
  6. Fatigue — 61 reports (9.06%)
  7. Vomiting — 61 reports (9.06%)
  8. Dyspnoea — 59 reports (8.77%)
  9. Diarrhoea — 53 reports (7.88%)
  10. Neutropenia — 52 reports (7.73%)

Source database →

Frequently asked questions

Is Investigational drug approved in United States?

Investigational drug does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Investigational drug in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.